Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biogen
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
2
×
chinook therapeutics
clinical trials
detroit blog main
detroit top stories
duchenne muscular dystrophy
eli lilly
2
×
fda
glaxosmithkline
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
a2 biotherapeutics
abbvie
What
bio
days
2
×
roundup
alliance
august
biotech
bristol
busy
buy
calls
changing
color
crispr
decisions
devices
drugs
fda
growing
hours
kudos
leaves
legacy
myers’s
news
nods
notifying
october
opioid
past
phone
regulatory
rnai
rouse
sarepta’s
scientists
seven
shkreli’s
shorter
slow
slumber
Language
unset
Current search:
glaxosmithkline
×
days
×
biogen
×
" bristol-myers squibb "
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More